በOklahoma ለT-ሴል ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለT-ሴል ሊምፎማ የሚደረጉ 3 ጥናቶች በOklahoma ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
Official study text (English)
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- University of Oklahoma Health Sciences Center, Oklahoma City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04803201Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- University of Oklahoma Health Sciences Center, Oklahoma City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06724237Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Saint Francis Children's Hospital, Tulsa
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06390319ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።